IZEA Form 4: Director Brian Brady Received 4,032 Restricted Shares
Brian W. Brady, a director of IZEA Worldwide, Inc. (IZEA), received 4,032 restricted shares on 09/30/2025 as compensation for Q3 2025 director fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brian W. Brady, a director of IZEA Worldwide, Inc. (IZEA), received 4,032 restricted shares on 09/30/2025 as compensation for Q3 2025 director fees. The award was valued at $15,000 based on the closing price of $3.7200 on the grant date and vested at grant, giving him immediate ownership. After the transaction Brady beneficially owned 453,020 shares. The Form 4 filing was executed by an attorney-in-fact and signed on 10/01/2025.
Positive
- Director compensation paid in equity: 4,032 restricted shares awarded for Q3 2025 director fees.
- Award vested at grant: The shares vested on the grant date, giving immediate ownership.
- Clear valuation disclosed: Award valued at $15,000 based on $3.7200 closing price on 09/30/2025.
- Beneficial ownership updated: Reporting person beneficially owns 453,020 shares after the transaction.
Negative
- None.
Insights
TL;DR: Director received immediaterestricted stock worth $15,000, increasing reported beneficial ownership to 453,020 shares.
The filing documents a routine director compensation payment in equity rather than cash. The award consisted of 4,032 restricted shares valued at $3.72 each and vested at grant, so the director obtained full ownership immediately. This raises reported beneficial ownership and demonstrates use of equity-based director compensation. There are no derivative transactions reported and no other material changes disclosed.
TL;DR: Governance action is standard: equity granted for director fees and vested on grant, disclosed via Form 4.
The Form 4 shows transparent reporting of a director fee settlement in restricted stock, explicitly stating vesting at grant and the valuation method tied to the closing market price. The signature by an attorney-in-fact complies with execution formalities. The disclosure is concise and limited to this single, non-derivative equity grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,032 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock received for Q3 2025 director fees valued at $15,000 based on the closing market price of $3.7200 on the grant date of September 30, 2025. Award vests at the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Brian W. Brady report on the IZEA Form 4?
Who signed the Form 4 filing for Brian W. Brady?
AI-generated analysis. How Rhea-AI works. Not financial advice.